Negative Feedback Regulation of Hypophysiotropic Thyrotropin-releasing Hormone (TRH) Synthesizing Neurons: Role of Neuronal Afferents and Type 2 Deiodinase

Overview

Journal Front Neuroendocrinol

Specialty Endocrinology

Date 2007 Jun 26

PMID 17588648

Citations 44

Authors

Csaba Fekete

Ronald M Lechan

Affiliations

Soon will be listed here.

Abstract

Hypophysiotropic thyrotropin-releasing hormone (TRH): synthesizing neurons reside in the hypothalamic paraventricular nucleus (PVN) and are the central regulators of the hypothalamic-pituitary-thyroid (HPT) axis. TRH synthesis and release from these neurons are primarily under negative feedback regulation by thyroid hormone. Under certain conditions such as cold exposure and fasting, however, inputs from neurons in the brainstem and hypothalamic arcuate and dorsomedial nuclei alter the set point for negative feedback through regulation of CREB phosphorylation. Thus, during cold exposure, adrenergic neurons stimulate the HPT axis, while fasting-induced central hypothyroidism is mediated through an arcuato-paraventricular pathway. Feedback regulation of TRH neurons may also be modified by local tissue levels of thyroid hormone regulated by the activation of type 2 iodothyronine deiodinase (D2), the primary enzyme in the brain that catalyzes T4 to T3 conversion. During infection, endotoxin or endotoxin induced cytokines increase D2 activity in the mediobasal hypothalamus, which by inducing local hyperthyroidism, may play an important role in infection-induced inhibition of hypophysiotropic TRH neurons.

Citing Articles

Adaptive Effects of Endocrine Hormones on Metabolism of Macronutrients during Fasting and Starvation: A Scoping Review.

Karimi R, Yanovich A, Elbarbry F, Cleven A Metabolites. 2024; 14(6).

PMID: 38921471 PMC: 11205672. DOI: 10.3390/metabo14060336.

Non-thyroidal disease syndrome in patients with systemic lupus erythematosus: relation to disease inflammatory activity.

Meng X, Lv A, Tang M, Liu X, Wang X, Li Y Clin Rheumatol. 2024; 43(5):1551-1558.

PMID: 38578510 DOI: 10.1007/s10067-024-06947-y.

Pharmacodynamics Research on Danggui-Shaoyao-San through Body Fluid Indexes of Spleen Deficiency-water Dampness Rats using Bio-impedance Technology.

Chen R, Yang M, Peng C, Yin D, Zhang Y, Xu F Curr Pharm Biotechnol. 2023; 25(12):1602-1616.

PMID: 37921128 DOI: 10.2174/0113892010243018231025065109.

Non-thyroidal illness syndrome and its relationship with mortality risk in critically ill children.

Carreras L, Riano I, Vivanco A, Avello N, Iglesias T, Rey C Front Pediatr. 2023; 11:1142332.

PMID: 36937966 PMC: 10020518. DOI: 10.3389/fped.2023.1142332.

Clinical Biology of the Pituitary Adenoma.

Melmed S, Kaiser U, Lopes M, Bertherat J, Syro L, Raverot G Endocr Rev. 2022; 43(6):1003-1037.

PMID: 35395078 PMC: 9695123. DOI: 10.1210/endrev/bnac010.

References

Montiel M, Morell M, Morata P . 5' Deiodinase activity in brain regions of adult rats: modifications in different situations of experimental hypothyroidism. Brain Res Bull. 1993; 30(5-6):611-6. DOI: 10.1016/0361-9230(93)90090-x. View

Nillni E, Sevarino K . The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocr Rev. 1999; 20(5):599-648. DOI: 10.1210/edrv.20.5.0379. View

Schwartz M, Sipols A, MARKS J, Sanacora G, White J, Scheurink A . Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 1992; 130(6):3608-16. DOI: 10.1210/endo.130.6.1597158. View

Fekete C, Wittmann G, Liposits Z, Lechan R . GABA-ergic innervation of thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Brain Res. 2002; 957(2):251-8. DOI: 10.1016/s0006-8993(02)03576-x. View

Fekete C, Kelly J, Mihaly E, Sarkar S, Rand W, Legradi G . Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology. 2001; 142(6):2606-13. DOI: 10.1210/endo.142.6.8207. View

Gereben B, Pachucki J, Kollar A, Liposits Z, Fekete C . Ontogenic redistribution of type 2 deiodinase messenger ribonucleic acid in the brain of chicken. Endocrinology. 2004; 145(8):3619-25. DOI: 10.1210/en.2004-0229. View

Coppola A, Meli R, Diano S . Inverse shift in circulating corticosterone and leptin levels elevates hypothalamic deiodinase type 2 in fasted rats. Endocrinology. 2005; 146(6):2827-33. DOI: 10.1210/en.2004-1361. View

Liao N, Vaudry H, Pelletier G . Neuroanatomical connections between corticotropin-releasing factor (CRF) and somatostatin (SRIF) nerve endings and thyrotropin-releasing hormone (TRH) neurons in the paraventricular nucleus of rat hypothalamus. Peptides. 1992; 13(4):677-80. DOI: 10.1016/0196-9781(92)90172-y. View

Brabant G, Prank K, Ranft U, Bergmann P, Schuermeyer T, Hesch R . Circadian and pulsatile TSH secretion under physiological and pathophysiological conditions. Horm Metab Res Suppl. 1990; 23:12-7. View

10.

Toni R, Jackson I, Lechan R . Thyrotropin-releasing-hormone-immunoreactive innervation of thyrotropin-releasing-hormone-tuberoinfundibular neurons in rat hypothalamus: anatomical basis to suggest ultrashort feedback regulation. Neuroendocrinology. 1990; 52(5):422-8. DOI: 10.1159/000125623. View

11.

Sagar S, Price K, Kasting N, Sharp F . Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Res Bull. 1995; 36(4):381-92. DOI: 10.1016/0361-9230(94)00217-o. View

12.

Crantz F, Silva J, Larsen P . An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology. 1982; 110(2):367-75. DOI: 10.1210/endo-110-2-367. View

13.

Harris M, Aschkenasi C, Elias C, Chandrankunnel A, Nillni E, Bjoorbaek C . Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest. 2001; 107(1):111-20. PMC: 198547. DOI: 10.1172/JCI10741. View

14.

Thonberg H, Fredriksson J, Nedergaard J, Cannon B . A novel pathway for adrenergic stimulation of cAMP-response-element-binding protein (CREB) phosphorylation: mediation via alpha1-adrenoceptors and protein kinase C activation. Biochem J. 2002; 364(Pt 1):73-9. PMC: 1222547. DOI: 10.1042/bj3640073. View

15.

Hahn T, Breininger J, Baskin D, Schwartz M . Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci. 1999; 1(4):271-2. DOI: 10.1038/1082. View

16.

Fekete C, Sarkar S, Lechan R . Relative contribution of brainstem afferents to the cocaine- and amphetamine-regulated transcript (CART) innervation of thyrotropin-releasing hormone synthesizing neurons in the hypothalamic paraventricular nucleus (PVN). Brain Res. 2005; 1032(1-2):171-5. DOI: 10.1016/j.brainres.2004.10.069. View

17.

Fliers E, Guldenaar S, Wiersinga W, Swaab D . Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab. 1997; 82(12):4032-6. DOI: 10.1210/jcem.82.12.4404. View

18.

Legradi G, Lechan R . Agouti-related protein containing nerve terminals innervate thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology. 1999; 140(8):3643-52. DOI: 10.1210/endo.140.8.6935. View

19.

Halaas J, Gajiwala K, Maffei M, Cohen S, Chait B, Rabinowitz D . Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995; 269(5223):543-6. DOI: 10.1126/science.7624777. View

20.

Fekete C, Mihaly E, Herscovici S, Salas J, Tu H, Larsen P . DARPP-32 and CREB are present in type 2 iodothyronine deiodinase-producing tanycytes: implications for the regulation of type 2 deiodinase activity. Brain Res. 2000; 862(1-2):154-61. DOI: 10.1016/s0006-8993(00)02105-3. View